IsoRay Medical Inc. will feature its new brand campaign for its existing proprietary Cesium-131 prostate cancer brachytherapy seed at ASTRO 2007.

Under the name Proxcelan, IsoRay Medical Inc. is expanding the marketing of its Cesium-131 seeds used in low dose radiation (LDR) permanent brachytherapy for prostate cancer. The reportedly fast-acting, high energy medical isotope has demonstrated strong clinical results and is being heralded as the first leap forward in seed brachytherapy in 20 years.

Siemens will showcase at ASTRO 2007 its CTVision, previously marketed under the name PRIMATOM, whichreportedly brings advanced image guidance to radiation treatment delivery by integrating a linear accelerator and a CT gantry that travels along rails (CT-on-rails), allowing for diagnostic imaging of the patient on the treatment table.

Siemens Medical Solutions will exhibit at ASTRO 2007 an alternative approach to IGRT, the MVision Megavoltage Cone Beam Imaging Package that is reportedly a powerful, unique volumetric in-line target imaging solution that employs the existing treatment beam to provide 3D target imaging.

Varian Medical Systems will unveil at ASTRO 2007 RapidArc, a radiotherapy technology that will reportedly make it possible to quickly deliver a complete intensity- modulated radiation treatment during a single rotation of the treatment machine around the patient while potentially conforming dose more closely to the size, shape and location of the tumor and sparing more surrounding healthy tissue.

October 24, 2007 — Study results presented this week at the Transcatheter Cardiovascular Therapeutic (TCT) annual meeting in Washington D.C., demonstrated that the use of GE's isosmolar contrast medium Visipaque (iodixanol) resulted in a statistically significantly lower rate of contrast-induced nephropathy (CIN) than the low osmolar nonionic contrast agent ioversol, according to the company.

October 24, 2007 - Seven in 10 primary care physicians believe that the medical house call, a vestige of medicine practiced in a bygone era and now beginning to make a comeback, will improve patient care and result in fewer emergency room visits and faster patient recuperation time and comfort, according to a recent survey of 7,000 primary care physicians in the New York, Chicago, Los Angeles and San Francisco metropolitan areas regarding their opinions and attitudes about medical house calls.

October 24, 2007 – Researchers for the Radiation Therapy Oncology Group (RTOG) have found that emotional well-being is not an independent factor in predicting the survival time of patients with head and neck cancer.

The details of their research appear in the Dec. 1 issue of CANCER.

October 24, 2007 - Since wildfires began raging across San Diego County Sunday, Oct. 21, Scripps Health has treated 166 patients affected by the blazes at its hospital-based emergency departments and urgent care facilities.

October 24, 2007 - STERIS Corporation said today it has received the first orders for its VaproSure Room Sterilizer from several U.S. hospitals.

Since being introduced in June, systems have been ordered by Wellmont Health System (Virginia, Tennessee, Kentucky), Lake Hospital System (Ohio), and the VA Boston Healthcare System (Massachusetts).

October 24, 2007 - Pioneer Surgical Technology (PST) today announced its acquisition of Angstrom Medica Inc., the first company to obtain FDA approval for a nanotechnology device, the NanOss.

Terms of the acquisition were not disclosed. Angstrom Medica becomes a wholly-owned subsidiary of PST and is part of its orthobiologics division.

NanOss chemistries enable products that are highly osteoconductive and can remodel over time into human bone. NanOss has potential application in trauma, spine and general orthopaedic markets.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now